Literature DB >> 21445879

Differential expression of complement proteins in cerebrospinal fluid from active multiple sclerosis patients.

Yun Li1, Zhaoyu Qin, Mingchong Yang, Yanjiang Qin, Chengzhao Lin, Shilian Liu.   

Abstract

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system with complex immunopathogenesis. Using the 2-D DIGE technology, we separate CSF proteins from patients with active MS and control subjects. Three of the seven differential proteins identified were related with complement system, and the network analysis of the differential proteins revealed complement activation involvement in active MS. Complement C4b (gamma chain) was confirmed elevated by performing western blotting analysis (P < 0.01). The present results are an independent quantitative proteomic measure in CSF from active MS patients. The differential expression of the complement C4b and related proteins in CSF provides potential biomarkers as well as evidence for the involvement of complement activation in the pathogenesis of MS disease.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21445879     DOI: 10.1002/jcb.23113

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

Review 1.  Proteomics in Multiple Sclerosis: The Perspective of the Clinician.

Authors:  Dániel Sandi; Zsófia Kokas; Tamás Biernacki; Krisztina Bencsik; Péter Klivényi; László Vécsei
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

Review 2.  The complement system as a biomarker of disease activity and response to treatment in multiple sclerosis.

Authors:  Alexandru Tatomir; Anamaria Talpos-Caia; Freidrich Anselmo; Adam M Kruszewski; Dallas Boodhoo; Violeta Rus; Horea Rus
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

3.  Vitamin D-binding protein in cerebrospinal fluid is associated with multiple sclerosis progression.

Authors:  Mingchong Yang; Zhaoyu Qin; Yanyan Zhu; Yun Li; Yanjiang Qin; Yongsheng Jing; Shilian Liu
Journal:  Mol Neurobiol       Date:  2013-01-22       Impact factor: 5.590

4.  Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.

Authors:  Shahin Aeinehband; Rickard P F Lindblom; Faiez Al Nimer; Swetha Vijayaraghavan; Kerstin Sandholm; Mohsen Khademi; Tomas Olsson; Bo Nilsson; Kristina Nilsson Ekdahl; Taher Darreh-Shori; Fredrik Piehl
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

5.  Sub-Chronic Neuropathological and Biochemical Changes in Mouse Visual System after Repetitive Mild Traumatic Brain Injury.

Authors:  Radouil Tzekov; Clint Dawson; Megan Orlando; Benoit Mouzon; Jon Reed; James Evans; Gogce Crynen; Michael Mullan; Fiona Crawford
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

6.  Utility of Two-Dimensional Difference Gel Electrophoresis in Diagnosis of Multiple Sclerosis.

Authors:  Michael Auer; Harald Hegen; Dagmar Rudzki; Georg Golderer; Florian Deisenhammer
Journal:  Diagnostics (Basel)       Date:  2018-07-05

7.  Mass spectrometry-based analysis of cerebrospinal fluid from arthritis patients-immune-related candidate proteins affected by TNF blocking treatment.

Authors:  Johanna Estelius; Johan Lengqvist; Elena Ossipova; Helena Idborg; Erwan Le Maître; Magnus L A Andersson; Lou Brundin; Mohsen Khademi; Elisabet Svenungsson; Per-Johan Jakobsson; Jon Lampa
Journal:  Arthritis Res Ther       Date:  2019-02-15       Impact factor: 5.156

8.  Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis.

Authors:  Ivan L Salazar; Ana S T Lourenço; Bruno Manadas; Inês Baldeiras; Cláudia Ferreira; Anabela Claro Teixeira; Vera M Mendes; Ana Margarida Novo; Rita Machado; Sónia Batista; Maria do Carmo Macário; Mário Grãos; Lívia Sousa; Maria João Saraiva; Alberto A C C Pais; Carlos B Duarte
Journal:  J Neuroinflammation       Date:  2022-02-08       Impact factor: 8.322

9.  Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response.

Authors:  Rickard P F Lindblom; Alexander Berg; Mikael Ström; Shahin Aeinehband; Cecilia A Dominguez; Faiez Al Nimer; Nada Abdelmagid; Matthias Heinig; Johan Zelano; Karin Harnesk; Norbert Hübner; Bo Nilsson; Kristina Nilsson Ekdahl; Margarita Diez; Staffan Cullheim; Fredrik Piehl
Journal:  J Neuroinflammation       Date:  2015-10-26       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.